审计与反馈对膀胱肿瘤电切质量的影响:RESECT试验单中心完成后评估
这项单中心前瞻性观察研究评估了RESECT审计反馈项目结束后TURBT质量的持续改善情况,纳入128例连续患者。结果显示 detrusor 肌肉采样率、切除完整性和SI-IVC使用率在审计后均提高,但无复发生存期无显著差异。
要点
- 审计反馈项目结束后TURBT质量指标持续改善
- detrusor 肌肉采样率从61.9%提升至85.9%
- SI-IVC使用率从0%升至25%
核心结论
- 参与全服务审计反馈项目后TURBT手术质量指标持续改善,但未检测到复发减少。
研究设计与样本
- 前瞻性观察性单中心队列研究,纳入2023年3月至2025年6月期间接受TURBT且符合RESECT标准的128例连续患者。
主要发现
- detrusor 肌肉存在率从审计前61.9%升至审计中70.7%和审计后85.9%(P < 0.001)。
- 切除完整性记录从88.4%升至96.3%和97.6%(P < 0.001),记录准确性各阶段均高(93.2%、96.3%、96.1%)。
- SI-IVC使用率从前两阶段的0%升至审计结束后的25%。
- 无复发生存期在各阶段间无显著差异。
关键数值与推荐
- detrusor 肌肉采样率:审计前61.9%,审计中70.7%,审计后85.9%(P < 0.001)。
- 切除完整性记录:审计前88.4%,审计中96.3%,审计后97.6%(P < 0.001)。
- 记录准确性:审计前93.2%,审计中96.3%,审计后96.1%。
- SI-IVC使用率:前两阶段0%,审计结束后25%。
临床怎么用
- 审计反馈项目可带来TURBT质量的持续改善,但需进一步研究明确哪些质量指标最能影响长期预后。
局限性
- 单中心研究,样本量有限,未检测到复发差异可能受多因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether improvements in transurethral resection of bladder tumour (TURBT) quality achieved during the RESECT international study (ClinicalTrials.gov identifier: NCT05154084) were sustained over time following completion of the programme at our institution and to investigate their effect on disease recurrence. PATIENTS AND METHODS: We conducted a prospective, observational monocentric cohort study at a tertiary university hospital. A total of 128 consecutive patients undergoing TURBT between March 2023 and June 2025 and meeting RESECT eligibility criteria were analysed. Four pre-defined surgical quality indicators-detrusor muscle sampling, completeness of resection, accuracy of operative documentation, and administration of single immediate intravesical chemotherapy (SI-IVC)-were compared across three institutional phases: pre-audit, prospective audit and post-audit RESECT periods. Recurrence-free survival (RFS) at follow-up was evaluated by cystoscopy and histological confirmation with TURBT. RESULTS: Detrusor muscle presence improved from 61.9% in the pre-audit phase to 70.7% during the prospective audit and 85.9% post-audit (P < 0.001). Completeness of resection documentation increased from 88.4% to 96.3% and 97.6%, respectively (P < 0.001), while documentation accuracy remained high across all phases (93.2%, 96.3%, and 96.1%). SI-IVC use rose from 0% in the first two phases to 25% after audit closure. Despite these improvements, RFS did not differ significantly between phases. CONCLUSION: Participation in a service-wide audit and feedback programme resulted in sustained improvements in TURBT surgical quality indicators after programme completion. This did not yield a detectable reduction in recurrence, highlighting the multifactorial nature of oncological outcomes in non-muscle-invasive bladder cancer. Further studies are required to identify which quality metrics most strongly influence long-term prognosis.
引用
- Orecchia L, Gerardi M, Colalillo G, et al. Impact of audit and feedback on transurethral resection of bladder tumour quality: a monocentric post-completion evaluation of the RESECT trial. BJU Int. 2026. PMID: 41919786. doi:10.1111/bju.70266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。